Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme.
作者信息
WARREN G H, GRAY J, YURCHENCO J A
出版信息
J Bacteriol. 1957 Dec;74(6):788-93. doi: 10.1128/jb.74.6.788-793.1957.
Abstract
摘要
相似文献
1
Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme.
J Bacteriol. 1957 Dec;74(6):788-93. doi: 10.1128/jb.74.6.788-793.1957.
2
[Meningitis due to "Neisseria catarrhalis." Cure by intraspinal polymyxin].
J Med Bord. 1960 Apr;137:392-6.
3
In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.
Antimicrob Agents Chemother. 1999 Apr;43(4):983-4. doi: 10.1128/AAC.43.4.983.
4
Comparison of three rapid methods, tributyrine, 4-methylumbelliferyl butyrate, and indoxyl acetate, for rapid identification of Moraxella catarrhalis.
J Clin Microbiol. 1994 May;32(5):1362-3. doi: 10.1128/jcm.32.5.1362-1363.1994.
5
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.
Antimicrob Agents Chemother. 1988 Dec;32(12):1747-53. doi: 10.1128/AAC.32.12.1747.
6
Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.
J Clin Microbiol. 1988 Dec;26(12):2544-8. doi: 10.1128/jcm.26.12.2544-2548.1988.
7
Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
Psychopharmacologia. 1959 Nov 3;1:109-16. doi: 10.1007/BF00409110.
8
[Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].
Helv Physiol Pharmacol Acta. 1957;15(1):1-7.
9
Observations on the metabolism of a strain of Neisseria catarrhalis.
J Bacteriol. 1950 Feb;59(2):277-86. doi: 10.1128/jb.59.2.277-286.1950.
10
Moraxella catarrhalis bacteraemia associated with prosthetic vascular graft infection.
J Med Microbiol. 2010 Feb;59(Pt 2):245-250. doi: 10.1099/jmm.0.013789-0. Epub 2009 Oct 22.
引用本文的文献
1
Synergy and Mechanism of the Action of the Combination of Essential Oils and Antibiotics Against Antibiotic-Resistant Food Borne Disease Bacteria in Burkina Faso.
Infect Drug Resist. 2025 May 30;18:2743-2763. doi: 10.2147/IDR.S518717. eCollection 2025.
2
Lipid Microenvironment Modulates the Pore-Forming Ability of Polymyxin B.
Antibiotics (Basel). 2022 Oct 20;11(10):1445. doi: 10.3390/antibiotics11101445.
3
Activation of a Bacterial Mechanosensitive Channel, MscL, Underlies the Membrane Permeabilization of Dual-Targeting Antibacterial Compounds.
Antibiotics (Basel). 2022 Jul 19;11(7):970. doi: 10.3390/antibiotics11070970.
4
A Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance.
Cell. 2020 Jun 25;181(7):1518-1532.e14. doi: 10.1016/j.cell.2020.05.005. Epub 2020 Jun 3.
5
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Front Cell Infect Microbiol. 2019 Apr 30;9:128. doi: 10.3389/fcimb.2019.00128. eCollection 2019.
6
Polymyxin: Alternative Mechanisms of Action and Resistance.
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a025288. doi: 10.1101/cshperspect.a025288.
7
Synergistic effects of miconazole and polymyxin B on microbial pathogens.
Vet Res Commun. 2009 Aug;33(6):489-505. doi: 10.1007/s11259-008-9194-z. Epub 2008 Dec 16.
8
Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides.
BMC Microbiol. 2008 Nov 11;8:196. doi: 10.1186/1471-2180-8-196.
9
Mechanisms of action of Polymyxin B on Chlorella and Scenedesmus.
Plant Physiol. 1959 Jul;34(4):380-9. doi: 10.1104/pp.34.4.380.
10
Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2006 May;50(5):1623-7. doi: 10.1128/AAC.50.5.1623-1627.2006.
本文引用的文献
1
The preparation and properties of a polysaccharide synthesized by Achromobacter fischeri.
J Bacteriol. 1951 Dec;62(6):779-84. doi: 10.1128/jb.62.6.779-784.1951.
2
Polymyxin B and polymyxin E; clinical and laboratory studies.
J Lab Clin Med. 1951 Mar;37(3):402-14.
3
The properties and mode of action of the polymyxins.
Bacteriol Rev. 1956 Mar;20(1):14-27. doi: 10.1128/br.20.1.14-27.1956.
4
The lysis of Pseudomonas aeruginosa by lysozyme.
J Bacteriol. 1955 Nov;70(5):614-9. doi: 10.1128/jb.70.5.614-619.1955.
5
The inhibition of lysozyme by acidic polymers from pathogenic bacteria.
J Bacteriol. 1955 Jul;70(1):110-2. doi: 10.1128/jb.70.1.110-112.1955.
6
Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations.
J Gen Microbiol. 1954 Jun;10(3):491-9. doi: 10.1099/00221287-10-3-491.
7
The depolymerization of bacterial polysaccharides by hyalyronidase preparations.
J Bacteriol. 1954 Feb;67(2):167-70. doi: 10.1128/jb.67.2.167-170.1954.
8
The release of soluble constituents from washed cells of Pseudomonas aeruginosa by the action of polymyxin.
J Gen Microbiol. 1953 Aug;9(1):54-64. doi: 10.1099/00221287-9-1-54.
9
Studies of the bacterial cell wall. IV. The composition of the cell walls of some Gram-positive and Gram-negative bacteria.
Biochim Biophys Acta. 1953 Apr;10(4):512-23. doi: 10.1016/0006-3002(53)90296-0.
Zotero 插件